Interest of clozapine and paliperidone palmitate plasma concentrations to monitor treatment in schizophrenic patients on chronic hemodialysis.
CHU Clermont-Ferrand, EA7280, Clermont-Ferrand University, Clermont-Ferrand, France. Electronic address: lsamalin@chu-clermontferrand.fr.
L
L
Samalin
CHU Clermont-Ferrand, EA7280, Clermont-Ferrand University, Clermont-Ferrand, France.
S
S
Lauron
CHU Clermont-Ferrand, EA7280, Clermont-Ferrand University, Clermont-Ferrand, France.
P M
PM
Llorca
D014150:Antipsychotic Agents / Q000097:blood* / Q000627:therapeutic use; D003024:Clozapine / Q000097:blood* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods*; D000068882:Paliperidone Palmitate / Q000097:blood* / Q000627:therapeutic use; D006435:Renal Dialysis / Q000379:methods*; D012563:Schizophrenia, Paranoid / Q000097:blood / Q000150:complications / Q000628:therapy*; D012907:Smoking / Q000097:blood
D014150:Antipsychotic Agents; D003024:Clozapine; D000068882:Paliperidone Palmitate